{
    "id": "2913a82f-aec0-b0af-e063-6294a90a4bf7",
    "code": {
        "code": "34391-3",
        "codeSystem": "2.16.840.1.113883.6.1",
        "displayName": "HUMAN PRESCRIPTION DRUG LABEL"
    },
    "name": "Ondansetron",
    "organization": "REMEDYREPACK INC.",
    "effectiveTime": "20241212",
    "ingredients": [
        {
            "name": "ASPARTAME",
            "code": "Z0H242BBR1"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A"
        },
        {
            "name": "SODIUM STEARYL FUMARATE",
            "code": "7CV7WJK4UI"
        },
        {
            "name": "ONDANSETRON",
            "code": "4AF302ESOS"
        }
    ],
    "indications": null,
    "contraindications": null,
    "warningsAndPrecautions": null,
    "adverseReactions": "6. common adults : prevention chemotherapy-induced ( ≥5 % ) : headache , malaise/fatigue , constipation , diarrhea . ( 6.1 ) prevention radiation-induced nausea vomiting ( ≥2 % ) : headache , constipation , diarrhea . ( 6.1 ) prevention postoperative nausea vomiting ( ≥9 % ) : headache hypoxia . ( 6.1 ) report suspected , contact glenmark pharmaceuticals inc. , usa 1 ( 888 ) 721-7115 fda 1-800-fda-1088 www.fda.gov/medwatch .",
    "adverseReactions_original": "6. Adverse Reactions The most common adverse reactions in adults for the: prevention of chemotherapy-induced (≥5%) are: headache, malaise/fatigue, constipation, diarrhea. ( 6.1) prevention of radiation-induced nausea and vomiting (≥2%) are: headache, constipation, and diarrhea. ( 6.1) prevention of postoperative nausea and vomiting (≥9%) are: headache and hypoxia. ( 6.1) To report SUSPECTED ADVERSE REACTIONS, contact Glenmark Pharmaceuticals Inc., USA at 1 (888) 721-7115 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch."
}